Ads
related to: BRISTOL-MYERS SQUIBB COMPANY
Search results
Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat - ADMA Biologics (NASDAQ:ADMA), ANI...
Benzinga· 21 hours agoBristol-Myers Squibb Company BMY reported an adjusted loss per share of $4.40, narrower than the...
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 1 day agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
BMYB34 | Bristol-Myers Squibb Company BDR Share Price - Investing.com NG
Investing.com· 1 day agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Q1 2024 Bristol-Myers Squibb Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 21 hours agoParticipants Adam Lenkowsky; Executive VP, Chief Commercialization Officer & Head of U.S. Oncology; Bristol-Myers Squibb Company Christopher S. Boerner; CEO & Chairman; Bristol-Myers Squibb ...
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Zacks via Yahoo Finance· 4 days agoBristol-Myers Squibb Company BMY is scheduled to report first-quarter 2024 results on Apr 25, before...
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
Seeking Alpha· 1 day agoBristol-Myers Squibb (BMY) stock dips even as the company topped consensus with Q1 2024 results, despite headwinds in its growth portfolio. Read more...
Bristol-Myers stock drops amid plans to cut jobs (NYSE:BMY)
Seeking Alpha· 1 day agoBristol-Myers Squibb (BMY) stock fell Thursday amid plans to lay off 2,200 employees as part of a...
Bristol-Myers Squibb (NYSE:BMY) Releases Earnings Results, Beats Expectations By $0.13 EPS
ETF DAILY NEWS· 17 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($4.40) EPS for the quarter, beating the consensus ...
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 5 days agoLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 2 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
